Rating History for Verrica Pharmaceuticals (VRCA) by Brookline Capital Markets
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 12/18/2025 | Kemp Dolliver | Upgrade | Buy (Hold) |
17.00 (N/A) |
8.60 (6.14) |
-28.6% | Details |
 |
|||||||
|
|||||||
|
|||||||
